News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
67,811 Results
Type
Article (2013)
Company Profile (20)
Press Release (65778)
Section
Business (31475)
Career Advice (49)
Deals (5084)
Drug Delivery (1)
Drug Development (8230)
Employer Resources (16)
FDA (1248)
Job Trends (1784)
News (43976)
Policy (2366)
Tag
Academia (132)
Academic (1)
Allergies (6)
Alliances (2510)
ALS (2)
Alzheimer's disease (125)
Antibody-drug conjugate (ADC) (12)
Approvals (1275)
Artificial intelligence (19)
Autoimmune disease (2)
Bankruptcy (19)
Best Places to Work (1670)
Biosimilars (7)
Biotechnology (17)
Bladder cancer (17)
Brain cancer (2)
Breast cancer (45)
Cancer (302)
Cardiovascular disease (24)
Career advice (44)
CAR-T (6)
Cell therapy (31)
Cervical cancer (5)
Clinical research (7344)
Collaboration (48)
Compensation (25)
COVID-19 (147)
CRISPR (5)
C-suite (4)
Cystic fibrosis (9)
Data (399)
Depression (1)
Diabetes (21)
Diagnostics (656)
Digital health (3)
Diversity, equity & inclusion (4)
Drug discovery (12)
Drug pricing (6)
Duchenne muscular dystrophy (4)
Earnings (27875)
Employer branding (2)
Employer resources (13)
Events (6984)
Executive appointments (22)
FDA (1484)
Frontotemporal dementia (2)
Funding (49)
Gene editing (9)
Generative AI (3)
Gene therapy (34)
GLP-1 (70)
Government (272)
Guidances (107)
Healthcare (2181)
IgA nephropathy (5)
Immunology and inflammation (12)
Indications (6)
Infectious disease (158)
Inflammatory bowel disease (16)
Inflation Reduction Act (1)
Influenza (3)
Intellectual property (4)
Interviews (7)
IPO (3913)
IRA (1)
Job creations (207)
Job search strategy (43)
Kidney cancer (3)
Labor market (5)
Layoffs (27)
Legal (449)
Liver cancer (8)
Lung cancer (48)
Lymphoma (22)
Machine learning (1)
Management (3)
Manufacturing (23)
MASH (13)
Medical device (1594)
Medtech (1594)
Mergers & acquisitions (1227)
Metabolic disorders (70)
Multiple sclerosis (18)
NASH (2)
Neurodegenerative disease (5)
Neuropsychiatric disorders (2)
Neuroscience (163)
NextGen: Class of 2025 (548)
Non-profit (281)
Now hiring (1)
Obesity (30)
Opinion (10)
Ovarian cancer (7)
Pain (5)
Pancreatic cancer (11)
Parkinson's disease (9)
Partnered (3)
Patents (15)
Patient recruitment (10)
Peanut (4)
People (2093)
Pharmaceutical (3)
Pharmacy benefit managers (1)
Phase I (1755)
Phase II (2936)
Phase III (3097)
Pipeline (606)
Policy (5)
Postmarket research (341)
Preclinical (561)
Press Release (1)
Prostate cancer (14)
Radiopharmaceuticals (21)
Rare diseases (40)
Real estate (290)
Recruiting (7)
Regulatory (1831)
Reports (10)
Research institute (155)
Resumes & cover letters (5)
Rett syndrome (1)
RNA editing (2)
RSV (5)
Schizophrenia (7)
Series A (7)
Series B (4)
Service/supplier (1)
Sickle cell disease (8)
Special edition (1)
Spinal muscular atrophy (6)
Startups (144)
Stomach cancer (4)
Supply chain (2)
Tariffs (3)
The Weekly (2)
Vaccines (73)
Weight loss (18)
Women's health (1)
Date
Today (46)
Last 7 days (281)
Last 30 days (574)
Last 365 days (4727)
2025 (1785)
2024 (5258)
2023 (5834)
2022 (6767)
2021 (7020)
2020 (6180)
2019 (4567)
2018 (3450)
2017 (3268)
2016 (2334)
2015 (3060)
2014 (2028)
2013 (1320)
2012 (1753)
2011 (2002)
2010 (1880)
Location
Africa (58)
Alabama (6)
Arizona (11)
Arkansas (2)
Asia (3464)
Australia (591)
California (907)
Canada (277)
China (49)
Colorado (46)
Connecticut (55)
Delaware (30)
Europe (9736)
Florida (114)
Georgia (39)
Idaho (3)
Illinois (52)
India (3)
Indiana (64)
Japan (15)
Kansas (8)
Kentucky (3)
Louisiana (4)
Maine (12)
Maryland (112)
Massachusetts (603)
Michigan (25)
Minnesota (52)
Missouri (8)
Montana (3)
Nebraska (3)
Nevada (6)
New Hampshire (9)
New Jersey (311)
New Mexico (1)
New York (268)
North Carolina (131)
Northern California (443)
Ohio (20)
Oregon (2)
Pennsylvania (194)
South America (88)
South Carolina (1)
Southern California (333)
Tennessee (17)
Texas (132)
United States (3314)
Utah (27)
Virginia (7)
Washington D.C. (5)
Washington State (111)
Wisconsin (5)
67,811 Results for "47".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
VenoValve to be Featured During Presentation at the 47th Annual Charing Cross Symposium
April 23, 2025
·
3 min read
Press Releases
BlackfinBio Announces FDA Clearance to Initiate Phase 1/2 Clinical Trial for Novel AAV Gene Therapy BFB-101 to Treat the Rare Neurological Disease Hereditary Spastic Paraplegia, Type 47 (SPG47)
April 28, 2025
·
4 min read
Press Releases
Ascletis Announces Positive Topline Results of Phase Ib Studies of ASC47 Monotherapy in Australia and U.S. FDA Clearance of IND Application for ASC47 in Combination with Semaglutide
March 12, 2025
·
6 min read
Press Releases
Ethris Receives €10 Million EU4Health Grant to Support Clinical Development and Expand Antiviral Applications of Lead mRNA Candidate ETH47
May 6, 2025
·
4 min read
Press Releases
Ascletis Announces Oral and Poster Presentations on ASC47, an Adipose-Targeted, Muscle-Preserving Weight Loss Drug Candidate for Obesity at the 32nd European Congress on Obesity
May 6, 2025
·
2 min read
Press Releases
Celltrion Receives EC Approval for Avtozma® (CT-P47), a Biosimilar to RoActemra® (tocilizumab)
February 24, 2025
·
6 min read
Press Releases
Palatin Announces $4.7 Million Registered Direct Offering and Concurrent Private Placement
February 7, 2025
·
5 min read
Press Releases
Stem Cells Market Size to Surge to $49.26 Billion by 2034 Driven by 11.47% CAGR
February 19, 2025
·
1 min read
Press Releases
Bioinformatics Market Size Leads 13.73% CAGR to Hit 47.48 Bn by 2034
February 6, 2025
·
1 min read
Business
Illumina Reports $1.47B ‘Goodwill’ Impairment Charge After Grail Spinoff
Following the recently completed spinoff of cancer detection company Grail, sequencing giant Illumina said Thursday it expects to absorb a $1.47 billion goodwill impairment charge.
June 28, 2024
·
2 min read
·
Tristan Manalac
1 of 6,782
Next
